Press Release

Novel approach from Synergy Pharmaceuticals may hold cure to herpes virus Feb 11, 2020 15:30 JST There is an immediate need for alternative treatments to combat the spread of Herpes type 1 & 2 strains. The United States alone reports over 750,000 new cases of herpes infections every year. More info..

Luye Announces 2016 Annual Results Mar 31, 2017 14:29 JST Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), a leading innovative pharmaceutical company in China with strong R&D capability and a global vision, announced on 29 March its annual results for the year ended 31 December 2016. More info..

Luye Pharma Announces the Completion of Acquisition of Acino's Transdermal Drug Delivery Systems Business
Dec 01, 2016 11:40 JST

Luye Pharma Group Ltd. (2186.HK) is pleased to announce the completion of its acquisition of the transdermal drug delivery systems (TDS) business from Swiss company, Acino. The acquired business is a global leader in niche transdermal markets and will greatly enhance Luye's developmental efforts in R&D,
More info..

Luye Pharma Takes a Milestone Step Forward; Proposed Acquisition of Acino's TDS Business
Jul 26, 2016 08:45 JST

Luye Pharma Group Ltd. (2186.HK) (the "Company", and together with its subsidiaries, "Luye Pharma" or the "Group") announces its agreement to acquire the TDS business from Acino, through the purchase of the entire issued share capital of Acino AG and Acino Supply AG (the "Target Group") for EUR245,000,000 (the "Acquisition").

More info..

Luye Medical welcomes Australia's Healthe Care to its Group
May 06, 2016 12:00 JST

Healthe Care, Australia's third largest private healthcare group, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund completed on April 18.
More info..

Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group Apr 24, 2016 06:30 JST On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. More info..

China's First Innovative Drug Led by Luye Pharma Approved NDA in the U.S.
Oct 09, 2015 20:40 JST

The leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), announced that the United States Food and Drug Administration (the "FDA") has confirmed that no additional clinical trials are needed for the New Drug Application ("NDA") submission for Risperidone Extended-release Microspheres for Injection ("LY03004") in the U.S.
More info..

Luye Pharma was Selected as a Constituent of The MSCI Global Standard Indexes- China Index
May 14, 2015 10:27 JST

A leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (stock code: 2186.HK), is pleased to announce that the Group has been selected as a constituent of Morgan Stanley Capital International ("MSCI") China Index under MSCI Global Standard Indexes and will take effect as of market close on 29 May 2015.

More info..

Luye Announces 2014 Annual Results Apr 01, 2015 10:49 JST A leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd., announced its annual results for the year ended 31 December 2014. More info..